Pharmaceutical Technology, March 2022 Issue

A New Route to Pharma GDP Compliance and Standardization

March 03, 2022

Quality/Regulations

46

3

A consensus-based approach to GDP lies at the heart of a new industry-wide program seeking to rationalize, standardize, and harmonize the adherence to pharma transportation norms and regulatory guidelines.

Standing in Solidarity

March 02, 2022

From The Editor

46

3

As Russia’s invasion of Ukraine continues, industry leaders speak out in condemnation of the actions taking place and pledge to provide aid to those in need.

An Overview of the UK’s National AI Strategy

March 02, 2022

Regulatory Watch

46

3

The UK’s National AI Strategy underpins the government’s long-term commitment and ambitions to enhancing the country’s digital ecosystem, with the health and life sciences sectors seen as pivotal contributors to meeting these aims.

A Rocky Road Ahead for Commissioner Califf

March 02, 2022

Regulatory Watch

46

3

Califf will face challenges that include COVID-19, opioids, and user fees.

Characterizing the Unseen Drama of Analytics

March 02, 2022

From The Editor

46

3

Borrowing is good, but invention is best.

The Importance of Batch Record Reviews During Audits

March 02, 2022

Ask the Expert

46

3

Auditors must have access to the batch records of the activities they are reviewing, says Siegfried Schmitt, vice president, Technical at Parexel.

Locating Logic in Pharma Manufacturing

March 02, 2022

From the CEO

46

3

Reducing US dependency on overseas pharma manufacturing may prove critical in navigating supply chain disruptions.